Palantir Falls 12% After Q3 Results as Analysts Lift Targets

Palantir Technologies dropped 11.7% over the past week to $175.40, posting its worst five-session performance in months even as analysts responded to Q3 results by raising price targets in bulk.

The earnings reaction is the most striking element of this week's setup. The stock fell 4.7% on November 3, the day after reporting, despite a wave of target increases that landed within hours of each other. Barclays lifted its target to $273 from $265, maintaining Overweight. Citigroup moved to $265 from $250, also with a Buy. Morgan Stanley, running at Equal-Weight, raised its target to $233 from $205. Truist, Piper Sandler and RBC also moved higher. The one clear holdout is RBC, whose analyst kept an Underperform rating even while lifting the target to $130 from $90, a level less than three-quarters of where the stock currently trades. The consensus still shows ten holds and a mean target near $185, though that figure reflects stale data predating the recent revision wave. The more relevant number is the cluster of fresh targets sitting between $230 and $273, all above the current price by 30% or more. The market's response to those targets has so far been to sell.

Short positioning does not explain the selloff. Short interest edged down 1.9% over the week to roughly 58.0 million shares, equal to 2.5% of the free float, one of the lower readings of the past six weeks. The borrow market is as loose as it gets: availability is effectively uncapped, with over 2.2 billion shares available to lend against 58 million borrowed. Cost to borrow is 0.22%, well below what it was at mid-October. There is no short-side squeeze mechanism and no structural pressure from the lending market. What drove the stock lower this week was selling by longs, not new shorts piling in.

Options traders have grown more defensive, though the degree is modest. The put/call ratio reached 1.15 on November 3, slightly above its 20-day average of 1.12 and a tick below the 52-week high of 1.16. The z-score of roughly 1.0 puts this in cautious but not alarmed territory. For context, the ratio has been trending up gradually since late September, when it ran near 1.05. The drift toward puts has been steady rather than acute. Wikipedia attention, one of the retail-interest signals tracked by ORTEX, registered a z-score of negative 1.68 as of November 2, meaning retail engagement with the stock is running well below its own 90-day average at the moment the stock is selling off.

The bull case that analysts are pricing in rests on Palantir's Ontology platform creating deep switching costs in enterprise and government workflows, with U.S. commercial revenue growing well above 100% year on year and gross margins near 88%. The bear case centres on federal budget dependency, conversion risk from AIP bootcamps to scaled contracts, and a valuation that remains extreme by any traditional measure: the price-to-earnings multiple is 74 times trailing earnings, the price-to-book ratio is 22.7 times, and EV/EBITDA sits at 53 times. Those multiples have all compressed over the past 30 days as the stock fell, but they are still priced for near-flawless execution. EPS momentum factors rank in the 94th percentile on a 30-day basis and 86th percentile over 90 days, reflecting how consistently Palantir has beaten expectations. The forward earnings yield factor, at the 45th percentile, is the data's way of saying the market is paying well above average for that consistency.

The alt data adds one footnote worth noting. Palantir's buyback spend rose for three consecutive quarters, with Q4 2025 representing the largest fourth-quarter buyback figure in the company's history since 2019 at $19.2 million. That is a modest absolute number for a company with a $421 billion market cap, and none of the alt data datasets covering Palantir have been measured to lead its reported financials. The insider picture is similarly low-signal: the only open-market activity in the recent trades log is director Alexander Moore's pre-planned 10b5-1 sales in October, totalling around $2.6 million across several tranches at prices between $193 and $201. Those were executed above current levels. The October 28 activity logged under three executives was grant-type transactions with no price attached, not open-market purchases.

Peers traded roughly in line with the decline. Atlassian fell 12.9% over the week. Rubrik dropped 14.2%. Dynatrace was the week's outlier, down 26.2% after its own earnings. Against that backdrop, PLTR's 11.7% decline looks like sector pressure rather than company-specific punishment, though the stock's inability to hold any of its pre-earnings gains into the print itself is the detail the analyst community will need to reconcile with targets that now sit 30% to 55% above where the stock is trading. The next earnings event is scheduled for February 1, 2027.